Electrophysiological actions of a new antiarrhythmic drug, bisaramil, on isolated heart preparations
- PMID: 1738760
- DOI: 10.1016/s1043-6618(05)80066-0
Electrophysiological actions of a new antiarrhythmic drug, bisaramil, on isolated heart preparations
Abstract
Electrophysiological effects of bisaramil--a new antiarrhythmic drug under clinical trial--were investigated on isolated heart preparations, at a concentration range of 2.3-23 x 10(-6) M. Bisaramil dose dependently decreased the maximum rate of depolarization (Vmax), action potential amplitude (APA) and overshoot (OS) both in auricle and in papillary muscle of guinea-pig heart. There was no significant and obvious effect on the duration of the action potential and the resting membrane potential was also unchanged. Bisaramil slowed the spontaneous frequency of pacemaker cells in rabbit sinus node preparation due to its inhibitory effect on slow diastolic depolarization (SDD). Bisaramil was able to inhibit slow Ca(2+)-action potentials induced by isoprenaline on K(+)-depolarized papillary muscle. Results obtained with transmembrane current measurements revealed that bisaramil inhibited both fast Na(+)-current and slow Ca(2+)-current in frog sinoauricular fibres at the same concentration. Bisaramil with a mixed mode of the action seems to be a very promising drug.
Similar articles
-
Tonic and use-dependent block of sodium currents in isolated cardiac myocytes by bisaramil.Br J Pharmacol. 1995 Jan;114(2):377-82. doi: 10.1111/j.1476-5381.1995.tb13237.x. Br J Pharmacol. 1995. PMID: 7881737 Free PMC article.
-
Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations.Naunyn Schmiedebergs Arch Pharmacol. 1991 Sep;344(3):323-30. doi: 10.1007/BF00183007. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1961258
-
Investigations to characterize a new antiarrhythmic drug bisaramil.Pharmacol Res. 1991 Aug;24(2):149-62. doi: 10.1016/1043-6618(91)90030-2. Pharmacol Res. 1991. PMID: 1684242
-
Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.Eur J Pharmacol. 1993 Mar 16;233(1):1-6. doi: 10.1016/0014-2999(93)90341-e. Eur J Pharmacol. 1993. PMID: 8472737
-
Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):398-405. doi: 10.1007/pl00004960. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9089672
Cited by
-
Tonic and use-dependent block of sodium currents in isolated cardiac myocytes by bisaramil.Br J Pharmacol. 1995 Jan;114(2):377-82. doi: 10.1111/j.1476-5381.1995.tb13237.x. Br J Pharmacol. 1995. PMID: 7881737 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous